Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate
(26)
- Computing and Computational Sciences Directorate (38)
- Energy Science and Technology Directorate (223)
- Fusion and Fission Energy and Science Directorate
(24)
- Information Technology Services Directorate (3)
- Isotope Science and Enrichment Directorate (7)
- National Security Sciences Directorate
(20)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (135)
- User Facilities (27)
Researcher
- Alexander I Wiechert
- Benjamin Manard
- Brian Sanders
- Charles F Weber
- Costas Tsouris
- Fred List III
- Gerald Tuskan
- Ilenne Del Valle Kessra
- Isaiah Dishner
- Jeff Foster
- Jerry Parks
- Joanna Mcfarlane
- John F Cahill
- Jonathan Willocks
- Josh Michener
- Keith Carver
- Liangyu Qian
- Louise G Evans
- Matt Vick
- Paul Abraham
- Richard Howard
- Richard L. Reed
- Thomas Butcher
- Vandana Rallabandi
- Vilmos Kertesz
- Xiaohan Yang
- Yang Liu

Enzymes for synthesis of sequenced oligoamide triads and tetrads that can be polymerized into sequenced copolyamides.
Contact
To learn more about this technology, email partnerships@ornl.gov or call 865-574-1051.

High-gradient magnetic filtration (HGMF) is a non-destructive separation technique that captures magnetic constituents from a matrix containing other non-magnetic species. One characteristic that actinide metals share across much of the group is that they are magnetic.

A pressure burst feature has been designed and demonstrated for relieving potentially hazardous excess pressure within irradiation capsules used in the ORNL High Flux Isotope Reactor (HFIR).

Detection of gene expression in plants is critical for understanding the molecular basis of plant physiology and plant responses to drought, stress, climate change, microbes, insects and other factors.

Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

The invention provides on-line analysis of droplets for mass spectrometry.